Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ir SpiroPNP Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111484533B discloses novel Ir-SpiroPNP catalysts achieving 99.8% ee in dialkyl ketone hydrogenation, offering cost reduction in pharmaceutical intermediate manufacturing.